Responses
Clinical/translational cancer immunotherapy
Original research
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
Compose a Response to This Article
Other responses
No responses have been published for this article.